Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-25-000153

Chief Medical Officer acquired 44,655 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2025-08-05 Option exercise +44,655 $0.68 $30,365 220,328 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2025-08-05 Option exercise · Stock Option (right to buy) −44,655 62,500 D: show line 2 in the form
Loading xslF345X05/wk-form4_1754602468.xml…